Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders - PubMed (original) (raw)

Review

Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders

Laura E Kwako et al. Biol Psychiatry. 2016.

Abstract

This article proposes a heuristic framework for the Addictions Neuroclinical Assessment that incorporates key functional domains derived from the neurocircuitry of addiction. We review how addictive disorders (ADs) are presently diagnosed and the need for new neuroclinical measures to differentiate patients who meet clinical criteria for addiction to the same agent while differing in etiology, prognosis, and treatment response. The need for a better understanding of the mechanisms provoking and maintaining addiction, as evidenced by the limitations of current treatments and within-diagnosis clinical heterogeneity, is articulated. In addition, recent changes in the nosology of ADs, challenges to current classification systems, and prior attempts to subtype individuals with ADs are described. Complementary initiatives, including the Research Domain Criteria project, that have established frameworks for the neuroscience of psychiatric disorders are discussed. Three domains-executive function, incentive salience, and negative emotionality-tied to different phases in the cycle of addiction form the core functional elements of ADs. Measurement of these domains in epidemiologic, genetic, clinical, and treatment studies will provide the underpinnings for an understanding of cross-population and temporal variation in addictions, shared mechanisms in addictive disorders, impact of changing environmental influences, and gene identification. Finally, we show that it is practical to implement such a deep neuroclinical assessment using a combination of neuroimaging and performance measures. Neuroclinical assessment is key to reconceptualizing the nosology of ADs on the basis of process and etiology, an advance that can lead to improved prevention and treatment.

Keywords: Addiction; Assessment; Diagnosis; Neuroimaging; Nosology; Substance use.

Published by Elsevier Inc.

PubMed Disclaimer

Figures

Figure 1

Figure 1

ANA Primary Domains and Variables for Ancillary Assessment

Figure 2

Figure 2

Proposed ANA Process from Data Capture to Precision Medicine Implementation

Comment in

Similar articles

Cited by

References

    1. Jellinek EM. Alcoholism, a genus and some of its species. Canadian Medical Association journal. 1960;83:1341–1345. - PMC - PubMed
    1. Leggio L, Kenna GA, Fenton M, Bonenfant E, Swift RM. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychology review. 2009;19:115–129. - PubMed
    1. Ball SA, Carroll KM, Babor TF, Rounsaville BJ. Subtypes of cocaine abusers: support for a type A-type B distinction. Journal of consulting and clinical psychology. 1995;63:115–124. - PubMed
    1. Falck RS, Wang J, Carlson RG. Crack cocaine trajectories among users in a midwestern American city. Addiction. 2007;102:1421–1431. - PubMed
    1. Sun J, Bi J, Chan G, Oslin D, Farrer L, Gelernter J, et al. Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. Addictive behaviors. 2012;37:1138–1144. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources